UPLC-HDMSE to discover serum biomarkers in adults with type 1 diabetes

Int J Biol Macromol. 2022 Nov 30:221:1161-1170. doi: 10.1016/j.ijbiomac.2022.09.085. Epub 2022 Sep 14.

Abstract

Type 1 diabetes (T1D) is a complex disease with metabolic and functional changes that can alter an individual's proteome. An LC-MS/MS analytical method, in an HDMSE system, was used to identify differentially expressed proteins in the high abundance protein-depleted serum of T1D patients and healthy controls. Samples were processed in Progenesis QI for Proteomics software. A functional enrichment of the proteins was performed with Gene Ontology and ToppGene, and the interactions were visualized by STRING 11.5. As a result, 139 proteins were identified, 14 of which were downregulated in the serum of patients with T1D compared to controls. Most of the differentially expressed proteins were shown to be involved with the immune system, inflammation, and growth hormone stimulus response, and were associated with the progression of T1D. Differential protein expression data showed for the first-time changes in CPN2 expression levels in the serum of patients with T1D. Our findings indicate that these proteins are targets of interest for future investigations and for validation of protein biomarkers in T1D.

Keywords: Proteomics; Tandem mass spectrometry; Type 1 diabetes.

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Blood Proteins
  • Chromatography, Liquid / methods
  • Diabetes Mellitus, Type 1* / metabolism
  • Humans
  • Proteome / genetics
  • Proteomics / methods
  • Tandem Mass Spectrometry / methods

Substances

  • Proteome
  • Biomarkers
  • Blood Proteins